Relapsed Refractory Malignant Central Nervous System Tumors clinical trials

Explore recruiting relapsed refractory malignant central nervous system tumors clinical trials.

Recruiting relapsed refractory malignant central nervous system tumors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Malignant Central Nervous System Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I study of anti-GD2 Chimeric Antigen Receptor-Expressing T cells in pediatric and young adult patients affected by relapsed/refractory central nervous system tumors

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Relapsed Refractory Malignant Central Nervous System Tumors trials by city

Relapsed Refractory Malignant Central Nervous System Tumors in Toronto Relapsed Refractory Malignant Central Nervous System Tumors in Vancouver Relapsed Refractory Malignant Central Nervous System Tumors in Montreal Relapsed Refractory Malignant Central Nervous System Tumors in Calgary Relapsed Refractory Malignant Central Nervous System Tumors in Edmonton Relapsed Refractory Malignant Central Nervous System Tumors in Ottawa Relapsed Refractory Malignant Central Nervous System Tumors in Winnipeg Relapsed Refractory Malignant Central Nervous System Tumors in Quebec City Relapsed Refractory Malignant Central Nervous System Tumors in Hamilton Relapsed Refractory Malignant Central Nervous System Tumors in Kitchener Relapsed Refractory Malignant Central Nervous System Tumors in London Relapsed Refractory Malignant Central Nervous System Tumors in Halifax Relapsed Refractory Malignant Central Nervous System Tumors in New York Relapsed Refractory Malignant Central Nervous System Tumors in Los Angeles Relapsed Refractory Malignant Central Nervous System Tumors in Chicago Relapsed Refractory Malignant Central Nervous System Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease